These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 22128878

  • 1. Dose proportionality and pharmacokinetics of fentanyl buccal soluble film in healthy subjects: a phase I, open-label, three-period, crossover study.
    Finn AL, Vasisht N, Stark JG, Gever LN, Tagarro I.
    Clin Drug Investig; 2012 Jan 01; 32(1):63-71. PubMed ID: 22128878
    [Abstract] [Full Text] [Related]

  • 2. Dose Proportionality and Pharmacokinetics of Fentanyl Buccal Soluble Film in Healthy Subjects : A Phase I, Open-Label, Three-Period, Crossover Study.
    Finn AL, Vasisht N, Stark JG, Gever LN, Tagarro I.
    Clin Drug Investig; 2012 Jan 01; 32(1):63-71. PubMed ID: 27933600
    [Abstract] [Full Text] [Related]

  • 3. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
    Darwish M, Tempero K, Kirby M, Thompson J.
    Clin Ther; 2006 May 01; 28(5):715-24. PubMed ID: 16861093
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetic properties of fentanyl effervescent buccal tablets: a phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 microg in healthy adult volunteers.
    Darwish M, Kirby M, Robertson P, Tracewell W, Jiang JG.
    Clin Ther; 2006 May 01; 28(5):707-14. PubMed ID: 16861092
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Formulation selection and pharmacokinetic comparison of fentanyl buccal soluble film with oral transmucosal fentanyl citrate: a randomized, open-label, single-dose, crossover study.
    Vasisht N, Gever LN, Tagarro I, Finn AL.
    Clin Drug Investig; 2009 May 01; 29(10):647-54. PubMed ID: 19715381
    [Abstract] [Full Text] [Related]

  • 7. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
    Swearingen D, Pennick M, Shojaei A, Lyne A, Fiske K.
    Clin Ther; 2007 Apr 01; 29(4):617-25. PubMed ID: 17617285
    [Abstract] [Full Text] [Related]

  • 8. Dose proportionality of fentanyl buccal tablet in doses ranging from 600 to 1300 microg in healthy adult subjects: a randomized, open-label, four-period, crossover, single-centre study.
    Darwish M, Kirby M, Robertson P, Tracewell W, Xie F.
    Clin Drug Investig; 2010 Apr 01; 30(6):365-73. PubMed ID: 20441245
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
    Zhao RK, Cheng G, Tang J, Song J, Peng WX.
    Clin Ther; 2009 May 01; 31(5):1022-36. PubMed ID: 19539103
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics and dose proportionality of fentanyl sublingual spray: a single-dose 5-way crossover study.
    Parikh N, Goskonda V, Chavan A, Dillaha L.
    Clin Drug Investig; 2013 Jun 01; 33(6):391-400. PubMed ID: 23605506
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics and tolerability of etamicastat following single and repeated administration in elderly versus young healthy male subjects: an open-label, single-center, parallel-group study.
    Nunes T, Rocha JF, Vaz-da-Silva M, Falcão A, Almeida L, Soares-da-Silva P.
    Clin Ther; 2011 Jun 01; 33(6):776-91. PubMed ID: 21704242
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of fentanyl buccal tablet: a pooled analysis and review.
    Darwish M, Xie F.
    Pain Pract; 2012 Apr 01; 12(4):307-14. PubMed ID: 21831253
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
    Kim BH, Shin KH, Kim J, Lim KS, Kim KP, Kim JR, Cho JY, Shin SG, Jang IJ, Yu KS.
    Clin Ther; 2009 Nov 01; 31(11):2755-64. PubMed ID: 20110017
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics and tolerability of different doses of fentanyl following sublingual administration of a rapidly dissolving tablet to cancer patients: a new approach to treatment of incident pain.
    Lennernäs B, Hedner T, Holmberg M, Bredenberg S, Nyström C, Lennernäs H.
    Br J Clin Pharmacol; 2005 Feb 01; 59(2):249-53. PubMed ID: 15676050
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics and dose proportionality of fentanyl effervescent buccal tablets in healthy volunteers.
    Darwish M, Tempero K, Kirby M, Thompson J.
    Clin Pharmacokinet; 2005 Feb 01; 44(12):1279-86. PubMed ID: 16372825
    [Abstract] [Full Text] [Related]

  • 16. An innovative phase I population pharmacokinetic approach to investigate the pharmacokinetics of an intranasal fentanyl spray in healthy subjects.
    Plock N, Facius A, Hartmann L, Baumann S, Nave R.
    Int J Clin Pharmacol Ther; 2013 Jun 01; 51(6):495-508. PubMed ID: 23611571
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic comparison of two nicotine transdermal systems, a 21-mg/24-hour patch and a 25-mg/16-hour patch: a randomized, open-label, single-dose, two-way crossover study in adult smokers.
    DeVeaugh-Geiss AM, Chen LH, Kotler ML, Ramsay LR, Durcan MJ.
    Clin Ther; 2010 Jun 01; 32(6):1140-8. PubMed ID: 20637967
    [Abstract] [Full Text] [Related]

  • 18. A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: a randomized, double-blind, two-period crossover study in healthy volunteers.
    Darwish M, Chang S, Hellriegel ET.
    Clin Ther; 2009 Jan 01; 31(1):108-14. PubMed ID: 19243711
    [Abstract] [Full Text] [Related]

  • 19. Single-dose and multi-dose delivery systems for intranasal fentanyl spray are bioequivalent as demonstrated in a replicate pharmacokinetic study.
    Nave R, Connolly SM, Popper L, Lahu G, Schmitt H.
    Int J Clin Pharmacol Ther; 2012 Oct 01; 50(10):751-9. PubMed ID: 22943926
    [Abstract] [Full Text] [Related]

  • 20. Absorption of fentanyl from fentanyl buccal tablet in cancer patients with or without oral mucositis: a pilot study.
    Darwish M, Kirby M, Robertson P, Tracewell W, Jiang JG.
    Clin Drug Investig; 2007 Oct 01; 27(9):605-11. PubMed ID: 17705569
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.